Ceryvyn Therapeutics logo
CYV

Ceryvyn Therapeutics

Pharmaceuticals, Biotechnology & Life Sciences

Short position

short percentage0.23%
reported shorts3.2M
shares on issue1.368B

Ceryvyn Therapeutics (ASX:CYV) has 0.23% of its shares on issue reported as short positions as of 5 Oct 2026, or about 3,196,278 shares. Over the past 30 days that figure has fallen 0.05 percentage points, and over 7 days it has been broadly flat. Its highest recorded short interest was 0.97% in September 2026. CYV is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Ceryvyn Therapeutics (CYV) company profile

Profile, insiders and operations

CYV intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required